Scandion Oncology A/S Working Capital to Net Assets Ratio
Scandion Oncology A/S working capital to net assets ratio. Scandion Oncology A/S (SCOL) has a Working Capital to Net Assets ratio of 98.3% as of December 2024. Working capital of Skr8.13 Million (current assets of Skr18.14 Million minus current liabilities of Skr10.01 Million) is measured against net assets of Skr8.27 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check tangible net worth ratio of Scandion Oncology A/S to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Scandion Oncology A/S (2017–2024)
Working capital to net assets ratio of Scandion Oncology A/S from 2017 to 2024. This chart shows how Scandion Oncology A/S's Working Capital to Net Assets ratio has evolved across 8 annual periods from 2017 to 2024. As of December 2024, the ratio stands at 98.3%, reflecting working capital of Skr8.13 Million against net assets of Skr8.27 Million SEK. See Scandion Oncology A/S (SCOL) liquidity interval to measure how many days the company can operate on defensive assets alone.
Scandion Oncology A/S Working Capital to Net Assets Ratio by Year (2017–2024)
Scandion Oncology A/S working capital to net assets ratio by year from 2017 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for Scandion Oncology A/S from 2017 to 2024, covering 8 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see SCOL total asset value.
| Year | WC/NA Ratio | Working Capital (SEK) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 98.3% | Skr8.13 Million | Skr8.27 Million | Skr18.14 Million | Skr10.01 Million | ▲ +1.2 pp |
| 2023 | 97.1% | Skr30.23 Million | Skr31.12 Million | Skr33.66 Million | Skr3.44 Million | ▼ -0.4 pp |
| 2022 | 97.5% | Skr68.60 Million | Skr70.33 Million | Skr86.86 Million | Skr18.25 Million | ▼ -1.2 pp |
| 2021 | 98.7% | Skr103.21 Million | Skr104.54 Million | Skr114.30 Million | Skr11.09 Million | ▼ -1.4 pp |
| 2020 | 100.2% | Skr156.10 Million | Skr155.87 Million | Skr186.12 Million | Skr30.03 Million | ▲ +1.1 pp |
| 2019 | 99.1% | Skr18.17 Million | Skr18.34 Million | Skr19.63 Million | Skr1.46 Million | ▼ -0.6 pp |
| 2018 | 99.7% | Skr12.54 Million | Skr12.57 Million | Skr13.53 Million | Skr992.64K | ▲ +2.1 pp |
| 2017 | 97.6% | Skr1.42 Million | Skr1.45 Million | Skr1.93 Million | Skr509.02K | — |